News / Events :: Ocuphire Pharma, Inc. (OCUP)

Recent News View All News

Ocuphire Announces Publication of ORION-1 Phase 2 Results for Nyxol in Clinical Ophthalmology and Presentation at the January OIS Presbyopia Innovation Showcase

January 20, 2021

Ocuphire Completes Enrollment in MIRA-2 Phase 3 Clinical Trial Investigating Nyxol® for Reversal of Mydriasis

January 6, 2021

Upcoming Events View Events

Ophthalmology Innovation Summit (OIS) Presbyopia Innovation Showcase

Jan 28, 2021

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings